Clinical Trial Update: Clinical Study to Assess the Efficacy of IMM-124E (Travelan®) in a Controlled Human Infection Model [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 trial evaluating IMM-124E (Travelan) for prevention of traveler’s diarrhea and related infectious diarrheas in a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infectious Diarrhea
• Traveler Diarrhea

Drugs mentioned

• Travelan (IMM-124E)

Snippet

Sponsor: Immuron Ltd. | Conditions: Diarrhea, Travelers Diarrhea | Phase 2 | Status: COMPLETED